Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $6.67 million. The enterprise value is $6.04 million.

Market Cap	6.67M
Enterprise Value	6.04M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 23.62 million shares outstanding. The number of shares has increased by 49.22% in one year.

Shares Outstanding	23.62M
Shares Change (YoY)	+49.22%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	42.44%
Owned by Institutions (%)	0.37%
Float	13.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.12
Forward PS	n/a
PB Ratio	8.61
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.17.

Current Ratio	3.88
Quick Ratio	n/a
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -411.70% and return on invested capital (ROIC) is -1,020.43%.

Return on Equity (ROE)	-411.70%
Return on Assets (ROA)	-366.40%
Return on Capital (ROIC)	-1,020.43%
Revenue Per Employee	$243,831
Profits Per Employee	-$3.07M
Employee Count	3
Asset Turnover	0.29
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.52% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	-85.52%
50-Day Moving Average	0.22
200-Day Moving Average	0.65
Relative Strength Index (RSI)	59.53
Average Volume (30 Days)	935,743

Short Selling Information

The latest short interest is 692,082, so 2.93% of the outstanding shares have been sold short.

Short Interest	692,082
Short Previous Month	149,057
Short % of Shares Out	2.93%
Short % of Float	5.09%
Short Ratio (days to cover)	0.60

Income Statement

In the last 12 months, Mangoceuticals had revenue of $731,493 and -$9.21 million in losses. Loss per share was -$0.57.

Revenue	731,493
Gross Profit	431,501
Operating Income	-9.22M
Pretax Income	-9.21M
Net Income	-9.21M
EBITDA	-9.19M
EBIT	-9.21M
Loss Per Share	-$0.57

Full Income Statement

Balance Sheet

The company has $755,948 in cash and $128,679 in debt, giving a net cash position of $627,269 or $0.03 per share.

Cash & Cash Equivalents	755,948
Total Debt	128,679
Net Cash	627,269
Net Cash Per Share	$0.03
Equity / Book Value	774,754
Book Value Per Share	0.03
Working Capital	607,382

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.00 million and capital expenditures -$3,519, giving a free cash flow of -$7.00 million.

Operating Cash Flow	-7.00M
Capital Expenditures	-3,519
Free Cash Flow	-7.00M
FCF Per Share	-$0.43

Full Cash Flow Statement

Margins

Gross margin is 58.99%, with operating and profit margins of -1,260.28% and -1,259.40%.

Gross Margin	58.99%
Operating Margin	-1,260.28%
Pretax Margin	-1,259.40%
Profit Margin	-1,259.40%
EBITDA Margin	-1,256.00%
EBIT Margin	-1,259.40%
FCF Margin	-957.07%

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.22%
Shareholder Yield	-49.22%
Earnings Yield	-138.11%
FCF Yield	-104.96%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mangoceuticals has an Altman Z-Score of -28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28
Piotroski F-Score	5